JUSTIN FOJO: Open Payments
NPI 1205447372 · HEATHROW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,678 in 194 payments from 25 companies in 2025. Trend: 2023 $2,815 · 2024 $3,182 · 2025 $4,678
Food & beverage: $4,570Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $532 |
| Regeneron Healthcare Solutions, Inc. | 12 | $476 |
| PFIZER INC. | 24 | $437 |
| ABBVIE INC. | 16 | $404 |
| GENZYME CORPORATION | 12 | $319 |
| Novartis Pharmaceuticals Corporation | 14 | $309 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $287 |
| UCB, Inc. | 14 | $286 |
| Galderma Laboratories, L.P. | 16 | $274 |
| Arcutis Biotherapeutics, Inc. | 7 | $182 |
Products named: DUPIXENT, TREMFYA, CIBINQO, Bimzelx, NEMLUVIO, SKYRIZI, Zoryve, ILUMYA.
Industry payments across FL — which companies pay providers there.
